<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR2">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Andersen</surname>
    <given-names>PI</given-names>
   </name>
   <name>
    <surname>Krpina</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Ianevski</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Shtaida</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Jo</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Koit</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Tenson</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Hukkanen</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Anthonsen</surname>
    <given-names>MW</given-names>
   </name>
   <name>
    <surname>Bjoras</surname>
    <given-names>M</given-names>
   </name>
  </person-group>
  <article-title>Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine</article-title>
  <source>Viruses</source>
  <year>2019</year>
  <volume>11</volume>
  <fpage>964</fpage>
  <pub-id pub-id-type="doi">10.3390/v11100964</pub-id>
  <?supplied-pmid 6832696?>
  <pub-id pub-id-type="pmid">6832696</pub-id>
 </element-citation>
</ref>
